Anna Mowry - Aug 19, 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CFO and Treasurer
Signature
/s/ Matthew Murphy, as Attorney-in-Fact
Stock symbol
NAUT
Transactions as of
Aug 19, 2022
Transactions value $
$40,219
Form type
4
Date filed
8/22/2022, 07:40 PM
Previous filing
Jun 28, 2022
Next filing
Mar 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $40.2K +17.5K +44.59% $2.30 56.8K Aug 19, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 17,500 shares purchased in the price range of $2.29 to $2.30 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.